These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12680158)

  • 1. Gene-environment interactions between the codon 194 polymorphism of XRCC1 and antioxidants influence lung cancer risk.
    Ratnasinghe DL; Yao SX; Forman M; Qiao YL; Andersen MR; Giffen CA; Erozan Y; Tockman MS; Taylor PR
    Anticancer Res; 2003; 23(1B):627-32. PubMed ID: 12680158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk.
    Ratnasinghe D; Yao SX; Tangrea JA; Qiao YL; Andersen MR; Barrett MJ; Giffen CA; Erozan Y; Tockman MS; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):119-23. PubMed ID: 11219768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Classen V; Bernges U; Philipp M
    Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.
    Ito H; Matsuo K; Hamajima N; Mitsudomi T; Sugiura T; Saito T; Yasue T; Lee KM; Kang D; Yoo KY; Sato S; Ueda R; Tajima K
    Carcinogenesis; 2004 Aug; 25(8):1395-401. PubMed ID: 15044328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
    Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC1 polymorphism and lung cancer risk.
    Schneider J; Classen V; Helmig S
    Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study.
    Hung RJ; Brennan P; Canzian F; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Borel S; Hall J; Boffetta P
    J Natl Cancer Inst; 2005 Apr; 97(8):567-76. PubMed ID: 15840879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene.
    van Gils CH; Bostick RM; Stern MC; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1279-84. PubMed ID: 12433703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
    Yin J; Vogel U; Ma Y; Qi R; Wang H
    Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
    Ryk C; Kumar R; Thirumaran RK; Hou SM
    Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
    Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis.
    Wang Y; Yang H; Li H; Li L; Wang H; Liu C; Zheng Y
    Cancer Lett; 2009 Nov; 285(2):134-40. PubMed ID: 19481337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer.
    Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F
    Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer.
    Zhang X; Miao X; Liang G; Hao B; Wang Y; Tan W; Li Y; Guo Y; He F; Wei Q; Lin D
    Cancer Res; 2005 Feb; 65(3):722-6. PubMed ID: 15705867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking--lung cancer association.
    Ratnasinghe D; Tangrea JA; Stewart C; Bhat NK; Virtamo J; Albanes D; Taylor PR
    Anticancer Res; 2001; 21(2B):1295-9. PubMed ID: 11396202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
    Liu G; Zhou W; Park S; Wang LI; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer; 2004 Dec; 101(12):2802-8. PubMed ID: 15534883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.